United States · FDA National Drug Code directory
Lidocaine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70752-113_99e31c06-b379-4dfe-84e3-b810376bccd2
- Product NDC
- 70752-113
- Form
- OINTMENT
- Composition / generic term
- Lidocaine
- Labeler
- QUAGEN PHARMACEUTICALS LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210420
- Source listing expiry
- 20261231
Source-listed ingredients
- LIDOCAINE — 50 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 CARTON (70752-113-03) / 35.44 g in 1 TUBE · 70752-113-03
- 50 g in 1 JAR (70752-113-04) · 70752-113-04
- 150 g in 1 JAR (70752-113-07) · 70752-113-07
- 250 g in 1 JAR (70752-113-13) · 70752-113-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →